About: Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 09 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) scientific article published on 09 March 2019 (en)
publication date	wds:Q64111364-DA8C1A69-ACA9-428E-916B-96450B5DEF75
publication date	2019-03-09 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64111364-0F9A7E6C-57AD-469F-A7B8-27FD34BE239F
language of work or name	English
cites work	wds:Q64111364-17AB489B-947C-47C5-8E29-96D9AC6DDC7C wds:Q64111364-28E09D45-2681-4D87-A645-523F73FDF9ED wds:Q64111364-508929FB-4920-4ABD-8252-E00B811436D7 wds:Q64111364-60187827-4942-4B9C-8060-843A05050122 wds:Q64111364-63466DEE-C227-47EB-9CD0-5DF356EF7D18 wds:Q64111364-6F450543-FBEC-4DB8-A065-8E45383846EF wds:Q64111364-6FDB54DD-F30F-4288-9E13-D79AFD12963C wds:Q64111364-70A2A901-2228-44BF-8D48-B46ED4134FA0 wds:Q64111364-733B5D7C-BDC4-4225-9681-E1DF95AF8704 wds:Q64111364-7F7C2059-F53D-4628-92D2-5BC28386457F wds:Q64111364-81A19EB5-9FC1-430F-94C9-9DD0C3D124DA wds:Q64111364-888AB7D2-F41A-47CB-92B2-F5B97C201F7E wds:Q64111364-981FE76D-337A-4218-9985-53D4872E3AAE wds:Q64111364-C00672AF-4228-436A-87C2-DD25AEDF7323 wds:Q64111364-C253A562-C837-4ABE-B525-9F03018D7422 wds:Q64111364-C8FC39C0-B21F-47FE-A22C-043AA4647973 wds:Q64111364-DAB361CC-1654-41AE-8725-4F43174D6E62 wds:Q64111364-DEF38BDF-D01D-4C3C-822E-CAEC1CC48202 wds:Q64111364-DF7B01E5-8F7E-4C4D-AC14-DE6A7E6C7CB0 wds:Q64111364-DFFE4730-409E-4C64-9FE9-BC62CC3CA7E3 wds:Q64111364-E6004DDB-024A-4F92-B104-6A4401301309 wds:Q64111364-F0268972-F1E7-4B98-9D11-9193685B88F9 wds:Q64111364-F207F94F-10EB-4756-BC67-E83CD74AD2E2 wds:Q64111364-F65FF8DA-CF70-4EE6-B008-A7D05DFB4157 wds:Q64111364-F7547076-B822-419F-8B02-96D39D43B807
cites work	Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. The PRECIS-2 tool: designing trials that are fit for purpose Ticagrelor versus clopidogrel in patients with acute coronary syndromes Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point Thrombus aspiration during ST-segment elevation myocardial infarction The randomized registry trial--the next disruptive technology in clinical research? Interrater reliability: the kappa statistic. Pragmatic Trials. Response variability to P2Y12 receptor inhibitors: expectations and reality A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research Consortium In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Clinical event adjudication in cardiovascular device trials: An Food and Drug Administration perspective. Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More? Generalizability in Pragmatic Trials Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
author name string	wds:Q64111364-62D22319-14A4-4EE9-B74E-B584B1FAFECB wds:Q64111364-75821F20-B530-41C7-85BB-74D3452C5ED9 wds:Q64111364-890994E6-04C8-4789-9549-CC6B48785C35 wds:Q64111364-9384267E-142F-41C7-8C32-768AEFE16B36 wds:Q64111364-D3CCB8BB-67DD-4FA5-8AE7-497D46EE44E0
author name string	Luc Janssens Raffaele Piccolo Kurt Huber Leonardo Bolognese Ivo Petrov
rdfs:label	Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (nl) Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) (en)
skos:prefLabel	Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (nl) Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) (en)
name	Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (nl) Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) (en)
author	wds:Q64111364-0398EC74-91B7-4F42-9F52-8C3F66A5BAC8 wds:Q64111364-0F3FF08F-D3E2-46C5-83AD-9F1849D6D135 wds:Q64111364-1005E999-7E7D-4860-B0A1-2634CBA250E4 wds:Q64111364-21E760BE-CD5B-47AB-AA20-6DAD28FC9916 wds:Q64111364-26DDCE62-40B2-4A5A-8B3B-9E35776A9E66 wds:Q64111364-38E2195F-66F8-438D-BE7A-9F75FB90EE34 wds:Q64111364-4BBFEDB4-33FF-419F-B387-984A6942908F wds:Q64111364-51ABA13D-EF68-4333-B5FA-4810ACEC6CB4 wds:Q64111364-65959A7A-FD5F-4A20-8C71-29C2BA52724A wds:Q64111364-6652B9A2-A874-4C52-9E45-C09248278D03 wds:Q64111364-6DD4AA0A-9301-42A5-9BFE-51F3E1E58DB9 wds:Q64111364-6FDCB972-5C27-4A24-BF57-6538B9609FCB wds:Q64111364-770A786B-3CF5-47C7-ADA0-5FDE5D8621C9 wds:Q64111364-8456E5B1-E353-4BAE-915E-F1BF795CDAB2 wds:Q64111364-98CC5089-EB77-4A43-8FFB-C8C064A2296E wds:Q64111364-9C34ED17-FDBE-4F38-B8B1-37BE9F766203 wds:Q64111364-A38DD2BD-E5A6-4F0C-82C4-A0F101E34402 wds:Q64111364-A94737EB-36C1-49E7-9F84-1BF2F750AD1A wds:Q64111364-AA4A2D7A-897E-4329-A290-08CE7A747723 wds:Q64111364-ADDAFED5-9F3A-4E48-BAE0-D02C7AF8803A wds:Q64111364-B7BA44B9-4FFD-4A78-94DD-FBBFA318C151 wds:Q64111364-B862DCB8-423C-484D-B901-E117F7DFCCB2 wds:Q64111364-C1F695E4-02E6-497D-BDA1-9332794CE822 wds:Q64111364-D0E3A9FA-8E2C-4036-BF01-99C6A2EBE075

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software